UK markets closed

ReNeuron Group plc (RENE.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
36.00+0.50 (+1.41%)
At close: 04:29PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 20.83M
Enterprise value 4.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)68.82
Price/book (mrq)1.47
Enterprise value/revenue 14.76
Enterprise value/EBITDA -0.37

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-71.60%
S&P500 52-week change 3-6.14%
52-week high 3135.00
52-week low 325.00
50-day moving average 334.64
200-day moving average 370.76

Share statistics

Avg vol (3-month) 3208.95k
Avg vol (10-day) 3164.46k
Shares outstanding 557.06M
Implied shares outstanding 6N/A
Float 835.62M
% held by insiders 130.32%
% held by institutions 137.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 324 Jan 2018

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Mar 2021
Most-recent quarter (mrq)30 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,994.16%

Management effectiveness

Return on assets (ttm)-37.13%
Return on equity (ttm)-91.32%

Income statement

Revenue (ttm)274k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)41.50%
Gross profit (ttm)-9.25M
EBITDA -10.7M
Net income avi to common (ttm)-9.49M
Diluted EPS (ttm)-18.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)17.42M
Total cash per share (mrq)0.31
Total debt (mrq)635k
Total debt/equity (mrq)4.49
Current ratio (mrq)3.02
Book value per share (mrq)0.25

Cash flow statement

Operating cash flow (ttm)-8.06M
Levered free cash flow (ttm)-5.83M